Primary Site >> Stomach Cancer

Gene >> TEF

Journal: Gastric Cancer. 2014 Apr;17(2):341-7.
Title: Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort.
Author: Pernot, Simon|Mitry, Emmanuel|Samalin, Emmanuelle|Dahan, Laetitia|Dalban, Cecile|Ychou, Marc|Seitz, Jean-Francois|Turki, Hajer|Mazard, Thibault|Zaanan, Aziz|Lepere, Celine|Vaillant, Jean-Nicolas|Landi, Bruno|Rougier, Philippe|Taieb, Julien
PMID: 23739764
Journal: Ann Oncol. 2015 Jan;26(1):149-56.
Title: Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study.
Author: Van Cutsem, E|Boni, C|Tabernero, J|Massuti, B|Middleton, G|Dane, F|Reichardt, P|Pimentel, F L|Cohn, A|Follana, P|Clemens, M|Zaniboni, A|Moiseyenko, V|Harrison, M|Richards, D A|Prenen, H|Pernot, S|Ecstein-Fraisse, E|Hitier, S|Rougier, P
PMID: 25416687